Blood: Think very scared, HIV-positive people also go to donate blood!

!---- Background: Antiretroviral therapy (ART), used to treat and pre-exposure prophylaxis (PrEP, which is to take precautions before infection, such as using condoms during sex) is an effective way to help end the HIV epidemic, however, the use of ART may affect the risk of transmission of blood transfusions from HIVpurpose: To conduct three different ART/PrEP prevalence analyses among blood donorsmethod: First, the use of liquid chromatography - series mass spectrometry blind method to detect HIV-positive blood donors and infected - non-reactive blood donors blood samples, to assess the application of ARTsecond, infections from six locations in the United States - non-reactive, 18-45 years old, male, first-time blood donors were tested for emtricitabine and tenofovirfinally, the use of pre-blooded prEP by men who participated in the 2017 CDC National HIV Behavioral Monitoring (NHBS) with men who participated in the 2017 CDC National HIV Behavioral Monitoring (NHBS) was evaluatedresults: Art was not detected in 300 infection-non-reactive blood donation samples, but 46 of the 299 hiv confirmed hiv-diagnosed blood donation samples (15.4%, 95% CI 11.5-20.0%) were confirmed to have been ART treatment9 of the 1,494 first-time male stakes (0.6%, 95% CI 0.03 - 1.1%) had taken Enqualabin and Tenofowein the NHBS MSM survey, 27 out of 591 respondents (4.8 percent, 95 percent CI 3.2 - 6.9 percent) reported donating blood in 2016 or 2017 and using PrEP during blood donationconclusion: HIV-positive people who receive ART treatment and those who receive PrEP hiv prevention preparation are donating blood! If blood screening tests do not detect HIV in the blood of an infected donor, it may lead to an increased risk of HIV transfusion transmission